Skip to content

Personality Traits and Biochemical Risk Phenotypes

Personality Traits and Biochemical Risk Phenotypes in Adults Undergoing Routine Health Assessment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07653048
Acronym
PHEBiP
Enrollment
1000
Registered
2026-06-17
Start date
2024-10-01
Completion date
2027-09-01
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperglycemia, Metabolic Syndrome, Prediabetes

Keywords

Personality Traits, Biomarkers, Prediabetes, Hyperglycemia, Occupational Health, Five-Factor Personality Inventory, Laboratory Abnormalities, Routine Health Assessment

Brief summary

This prospective observational study investigates the association between personality traits and routine laboratory abnormalities in adults undergoing routine health assessment. Personality traits are assessed using the Five-Factor Personality Inventory (FFPI), while biochemical data are obtained from routine laboratory testing, including markers of glycemic status, liver function, lipid metabolism, renal function, and complete blood count parameters. The primary objective of the study is to evaluate the association between FFPI personality trait scores and the total number of laboratory abnormalities identified during routine clinical evaluation. Secondary analyses will examine associations between personality traits and glycemic status, fasting plasma glucose concentration, liver function markers, lipid profile parameters, renal function indicators, complete blood count parameters, and the total number of laboratory abnormalities. The findings may contribute to a better understanding of the relationship between psychological characteristics and biological health indicators and may support the development of more personalized approaches to health promotion, risk assessment, and disease prevention.

Detailed description

The study is designed as a prospective observational cohort investigation conducted in adults undergoing routine health assessment. Participants complete the Five-Factor Personality Inventory (FFPI), and clinical and laboratory data are collected as part of routine medical evaluation. Routine laboratory assessment includes fasting plasma glucose (mg/dL), gamma-glutamyl transferase (GGT, U/L), alanine aminotransferase (ALT, U/L), aspartate aminotransferase (AST, U/L), total cholesterol (mg/dL), serum creatinine (mg/dL), urea (mg/dL), estimated glomerular filtration rate (eGFR, mL/min/1.73 m²), and complete blood count parameters measured according to standard laboratory units. The total number of laboratory abnormalities is defined as the count of laboratory parameters outside their corresponding reference intervals. For the purposes of this study, the total number of laboratory abnormalities serves as an operational indicator of biochemical risk. The primary objective of the study is to evaluate the association between Five-Factor Personality Inventory (FFPI) personality trait scores and the total number of routine laboratory abnormalities identified during clinical evaluation. Secondary analyses will examine associations between personality traits and glycemic status, fasting plasma glucose concentration, liver function markers (GGT, ALT, and AST), lipid profile parameters, renal function indicators, and the total number of laboratory abnormalities. Data are collected prospectively during routine clinical practice. Statistical analyses will evaluate the strength and direction of associations between personality traits and laboratory health indicators while accounting for relevant demographic and clinical variables.

Interventions

None listed

Sponsors

Medical Center TOPMED
Lead SponsorOTHER
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 years or older * Undergoing routine health assessment * Completion of the Five-Factor Personality Inventory (FFPI) * Availability of routine laboratory test results * Provision of written informed consent

Exclusion criteria

* Age younger than 18 years * Incomplete FFPI assessment * Missing or incomplete laboratory data * Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Number of Laboratory AbnormalitiesAt baselineTotal number of routine laboratory parameters outside their corresponding reference intervals, expressed as a count of abnormal laboratory findings. Laboratory parameters include fasting plasma glucose (mg/dL), gamma-glutamyl transferase (GGT, U/L), alanine aminotransferase (ALT, U/L), aspartate aminotransferase (AST, U/L), total cholesterol (mg/dL), serum creatinine (mg/dL), urea (mg/dL), estimated glomerular filtration rate (eGFR, mL/min/1.73 m²), and complete blood count parameters measured according to standard laboratory units.

Secondary

MeasureTime frameDescription
Five-Factor Personality Inventory (FFPI) ScoresAt baselinePersonality traits assessed using the Five-Factor Personality Inventory (FFPI), including Neuroticism, Extraversion, Agreeableness, Conscientiousness, and Openness dimensions, expressed as standardized questionnaire scores.
Glycemic StatusAt baselineClassification of participants according to fasting plasma glucose (mg/dL) concentration measured during routine laboratory assessment as: Normoglycemia (\<100 mg/dL) Prediabetes (100-125 mg/dL) Hyperglycemia (≥126 mg/dL or previously diagnosed diabetes mellitus)

Countries

Romania

Contacts

CONTACTStefania Diana St Nilca, Principal Psychologist, PhD St
diana.nilca@umfst.ro+40745404037
PRINCIPAL_INVESTIGATORStefania Diana St Nilca, Principal Psychologist, PhD St

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026